2-Bromo-4-fluoro-5-(trifluoromethyl)aniline, 97.0%, 100g

N-(4-Fluoro-2-nitrophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

(S)-Methyl 2,3-diaminopropanoate dihydrochloride, 97.0%, 1g

5-(4-Methoxy-3-methylphenyl)-5-oxovaleric acid, 97.0%, 1g

1,1'-(2,6-Pyridinediyl)bis(3-methylimidazolium) Dibromide>98.0%(HPLC)(T)5g

(2-Chlorophenyl)acetaldehyde, 95.0%, 5g

1-(tert-Butoxycarbonyl)-4-[2-(trifluoromethyl)phenyl]piperidine-4-carboxylic aci, 1g

3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95%, 10g

5-Chloro-4-methyl-2,3-dihydropyridazin-3-one, 97%, 1g

tert-butyl 3-(bromomethyl)-3-hydroxyazetidine-1-carboxylate, 95.0%, 500mg

Calcium gluconate hydrate 1 g

SPE Cartridges CHROMAFIX® Alox N, 0.8 ml, Medium, 50 Piece(s)

2-METHYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4(1H)-ONE, 95.0%, 100mg